{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:31:50Z","timestamp":1789115510159,"version":"build-2803163510"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Greek General Secretariat of Research and Innovation","award":["T1EDK-00617\/MIS-5048548"],"award-info":[{"award-number":["T1EDK-00617\/MIS-5048548"]}]},{"name":"Greek General Secretariat of Research and Innovation","award":["T1EDK-00617\/MIS-5048548"],"award-info":[{"award-number":["T1EDK-00617\/MIS-5048548"]}]},{"name":"Greek General Secretariat of Research and Innovation","award":["T1EDK-00617\/MIS-5048548"],"award-info":[{"award-number":["T1EDK-00617\/MIS-5048548"]}]},{"name":"European Social Fund, implemented by the State Scholarships Foundation (IK\u03a5).","award":["MIS-5000432"],"award-info":[{"award-number":["MIS-5000432"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03180-2","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T12:05:00Z","timestamp":1749643500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Transcriptomic analysis reveals shared deregulated neutrophil responses in COVID-19 and idiopathic pulmonary fibrosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Georgios","family":"Divolis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Synolaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodoula","family":"Tringidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyrios","family":"Tzouvelekis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios T.","family":"Boumpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Skendros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna-Evdokia","family":"Galani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"3180_CR1","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S2213-2600(22)00401-5","volume":"10","author":"MJ Schultz","year":"2022","unstructured":"Schultz MJ, van Meenen DM, Bos LD. COVID-19-related acute respiratory distress syndrome: lessons learned during the pandemic. Lancet Respir Med. 2022;10:1108\u201310.","journal-title":"Lancet Respir Med"},{"key":"3180_CR2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/qjmed\/hcad092","volume":"116","author":"S O\u2019Reilly","year":"2023","unstructured":"O\u2019Reilly S. Pulmonary fibrosis in COVID-19: mechanisms, consequences and targets. QJM. 2023;116:750\u20134.","journal-title":"QJM"},{"key":"3180_CR3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","volume":"400","author":"LDJ Bos","year":"2022","unstructured":"Bos LDJ, Ware LB. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet. 2022;400:1145\u201356.","journal-title":"Lancet"},{"key":"3180_CR4","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.molmed.2023.08.010","volume":"29","author":"T Koudstaal","year":"2023","unstructured":"Koudstaal T, Funke-Chambour M, Kreuter M, Molyneaux PL, Wijsenbeek MS. Pulmonary fibrosis: from pathogenesis to clinical decision-making. Trends Mol Med. 2023;29:1076\u201387.","journal-title":"Trends Mol Med"},{"key":"3180_CR5","doi-asserted-by":"crossref","unstructured":"Silva MJA, Ribeiro LR, Gouveia MIM, Marcelino BDR, Santos CSD, Lima KVB, Lima L. Hyperinflammatory response in COVID-19: a systematic review. Viruses. 2023;15:553.","DOI":"10.3390\/v15020553"},{"key":"3180_CR6","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.immuni.2021.06.006","volume":"54","author":"GL Burn","year":"2021","unstructured":"Burn GL, Foti A, Marsman G, Patel DF, Zychlinsky A. The neutrophil. Immunity. 2021;54:1377\u201391.","journal-title":"Immunity"},{"key":"3180_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1189\/jlb.4VMR1114-555R","volume":"98","author":"IE Galani","year":"2015","unstructured":"Galani IE, Andreakos E. Neutrophils in viral infections: current concepts and caveats. J Leukoc Biol. 2015;98:557\u201364.","journal-title":"J Leukoc Biol"},{"key":"3180_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","volume":"61","author":"V Mutua","year":"2021","unstructured":"Mutua V, Gershwin LJ. A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics. Clin Rev Allergy Immunol. 2021;61:194\u2013211.","journal-title":"Clin Rev Allergy Immunol"},{"key":"3180_CR9","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532\u20135.","journal-title":"Science"},{"key":"3180_CR10","doi-asserted-by":"crossref","unstructured":"Dominguez-Diaz C, Varela-Trinidad GU, Munoz-Sanchez G, Solorzano-Castanedo K, Avila-Arrezola KE, Iniguez-Gutierrez L, Delgado-Rizo V, Fafutis-Morris M. To trap a pathogen: neutrophil extracellular traps and their role in mucosal epithelial and skin diseases. Cells. 2021;10:1469.","DOI":"10.3390\/cells10061469"},{"key":"3180_CR11","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1152\/physrev.00012.2018","volume":"99","author":"PX Liew","year":"2019","unstructured":"Liew PX, Kubes P. The neutrophil\u2019s role during health and disease. Physiol Rev. 2019;99:1223\u201348.","journal-title":"Physiol Rev"},{"key":"3180_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera A, Soehnlein O, Kenne E. Neutrophils in chronic inflammatory diseases. Cell Mol Immunol. 2022;19:177\u201391.","journal-title":"Cell Mol Immunol"},{"key":"3180_CR13","doi-asserted-by":"publisher","first-page":"21519","DOI":"10.1038\/s41598-021-00927-x","volume":"11","author":"L Prozan","year":"2021","unstructured":"Prozan L, Shusterman E, Ablin J, Mitelpunkt A, Weiss-Meilik A, Adler A, Choshen G, Kehat O. Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection. Sci Rep. 2021;11:21519.","journal-title":"Sci Rep"},{"key":"3180_CR14","doi-asserted-by":"publisher","first-page":"680134","DOI":"10.3389\/fimmu.2021.680134","volume":"12","author":"J Hazeldine","year":"2021","unstructured":"Hazeldine J, Lord JM. Neutrophils and COVID-19: active participants and rational therapeutic targets. Front Immunol. 2021;12:680134.","journal-title":"Front Immunol"},{"key":"3180_CR15","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1172\/JCI141374","volume":"130","author":"P Skendros","year":"2020","unstructured":"Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, Ntinopoulou M, Sertaridou E, Tsironidou V, Tsigalou C, et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 2020;130:6151\u20137.","journal-title":"J Clin Invest"},{"key":"3180_CR16","doi-asserted-by":"publisher","first-page":"821007","DOI":"10.3389\/fimmu.2022.821007","volume":"13","author":"M Pastorek","year":"2022","unstructured":"Pastorek M, Dubrava M, Celec P. On the origin of neutrophil extracellular traps in COVID-19. Front Immunol. 2022;13:821007.","journal-title":"Front Immunol"},{"key":"3180_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12985-023-02116-w","volume":"20","author":"J Li","year":"2023","unstructured":"Li J, Zhang K, Zhang Y, Gu Z, Huang C. Neutrophils in COVID-19: recent insights and advances. Virol J. 2023;20:169.","journal-title":"Virol J"},{"key":"3180_CR18","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1038\/s41418-021-00805-z","volume":"28","author":"M Ackermann","year":"2021","unstructured":"Ackermann M, Anders HJ, Bilyy R, Bowlin GL, Daniel C, De Lorenzo R, Egeblad M, Henneck T, Hidalgo A, Hoffmann M, et al. Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death Differ. 2021;28:3125\u201339.","journal-title":"Cell Death Differ"},{"key":"3180_CR19","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","volume":"182","author":"J Schulte-Schrepping","year":"2020","unstructured":"Schulte-Schrepping J, Reusch N, Paclik D, Bassler K, Schlickeiser S, Zhang B, Kramer B, Krammer T, Brumhard S, Bonaguro L, et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell. 2020;182:1419\u201340.e23.","journal-title":"Cell"},{"key":"3180_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13073-020-00823-5","volume":"13","author":"AC Aschenbrenner","year":"2021","unstructured":"Aschenbrenner AC, Mouktaroudi M, Kramer B, Oestreich M, Antonakos N, Nuesch-Germano M, Gkizeli K, Bonaguro L, Reusch N, Bassler K, et al. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Genome Med. 2021;13:7.","journal-title":"Genome Med"},{"key":"3180_CR21","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1182\/bloodadvances.2020003568","volume":"5","author":"ML Meizlish","year":"2021","unstructured":"Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, Chang CH, Zhang H, Shallow M, Bahel P, et al. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv. 2021;5:1164\u201377.","journal-title":"Blood Adv"},{"key":"3180_CR22","doi-asserted-by":"publisher","first-page":"204589402096654","DOI":"10.1177\/2045894020966547","volume":"10","author":"AB Pine","year":"2020","unstructured":"Pine AB, Meizlish ML, Goshua G, Chang CH, Zhang H, Bishai J, Bahel P, Patel A, Gbyli R, Kwan JM, et al. Circulating markers of angiogenesis and endotheliopathy in COVID-19. Pulm Circ. 2020;10:2045894020966547.","journal-title":"Pulm Circ"},{"key":"3180_CR23","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/infdis\/jiab108","volume":"223","author":"E Synolaki","year":"2021","unstructured":"Synolaki E, Papadopoulos V, Divolis G, Tsahouridou O, Gavriilidis E, Loli G, Gavriil A, Tsigalou C, Tziolos NR, Sertaridou E, et al. The Activin\/Follistatin axis is severely deregulated in COVID-19 and independently associated with in-hospital mortality. J Infect Dis. 2021;223:1544\u201354.","journal-title":"J Infect Dis"},{"key":"3180_CR24","doi-asserted-by":"publisher","first-page":"797292","DOI":"10.3389\/fphar.2021.797292","volume":"12","author":"Q Mei","year":"2021","unstructured":"Mei Q, Liu Z, Zuo H, Yang Z, Qu J. Idiopathic pulmonary fibrosis: an update on pathogenesis. Front Pharmacol. 2021;12:797292.","journal-title":"Front Pharmacol"},{"key":"3180_CR25","doi-asserted-by":"crossref","unstructured":"Podolanczuk AJ, Thomson CC, Remy-Jardin M, Richeldi L, Martinez FJ, Kolb M, Raghu G. Idiopathic pulmonary fibrosis: state of the art for 2023. Eur Respir J. 2023;61:2200957.","DOI":"10.1183\/13993003.00957-2022"},{"key":"3180_CR26","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1378\/chest.112.5.1338","volume":"112","author":"Y Obayashi","year":"1997","unstructured":"Obayashi Y, Yamadori I, Fujita J, Yoshinouchi T, Ueda N, Takahara J. The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis. Chest. 1997;112:1338\u201343.","journal-title":"Chest"},{"key":"3180_CR27","doi-asserted-by":"crossref","unstructured":"Achaiah A, Rathnapala A, Pereira A, Bothwell H, Dwivedi K, Barker R, Iotchkova V, Benamore R, Hoyles RK, Ho LP. Neutrophil lymphocyte ratio as an indicator for disease progression in idiopathic pulmonary fibrosis. BMJ Open Respir Res. 2022;9:e001202.","DOI":"10.1136\/bmjresp-2022-001202"},{"key":"3180_CR28","doi-asserted-by":"crossref","unstructured":"Huang E, Peng N, Xiao F, Hu D, Wang X, Lu L. The roles of immune cells in the pathogenesis of fibrosis. Int J Mol Sci. 2020;21:5203.","DOI":"10.3390\/ijms21155203"},{"key":"3180_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1189\/jlb.3HI1014-493R","volume":"98","author":"AD Gregory","year":"2015","unstructured":"Gregory AD, Kliment CR, Metz HE, Kim KH, Kargl J, Agostini BA, Crum LT, Oczypok EA, Oury TA, Houghton AM. Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis. J Leukoc Biol. 2015;98:143\u201352.","journal-title":"J Leukoc Biol"},{"key":"3180_CR30","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198:e44\u201368.","journal-title":"Am J Respir Crit Care Med"},{"key":"3180_CR31","doi-asserted-by":"publisher","first-page":"1447608","DOI":"10.3389\/fimmu.2024.1447608","volume":"15","author":"E Gavriilidis","year":"2024","unstructured":"Gavriilidis E, Divolis G, Natsi AM, Kafalis N, Kogias D, Antoniadou C, Synolaki E, Pavlos E, Koutsi MA, Didaskalou S, et al. Neutrophil-fibroblast crosstalk drives immunofibrosis in Crohn\u2019s disease through IFNalpha pathway. Front Immunol. 2024;15:1447608.","journal-title":"Front Immunol"},{"key":"3180_CR32","doi-asserted-by":"publisher","first-page":"951232","DOI":"10.3389\/fimmu.2022.951232","volume":"13","author":"I Mitroulis","year":"2022","unstructured":"Mitroulis I, Chrysanthopoulou A, Divolis G, Ioannidis C, Ntinopoulou M, Tasis A, Konstantinidis T, Antoniadou C, Soteriou N, Lallas G, et al. A gene expression map of host immune response in human brucellosis. Front Immunol. 2022;13:951232.","journal-title":"Front Immunol"},{"key":"3180_CR33","doi-asserted-by":"publisher","first-page":"fcz028","DOI":"10.1093\/braincomms\/fcz028","volume":"1","author":"G Divolis","year":"2019","unstructured":"Divolis G, Stavropoulos A, Manioudaki M, Apostolidou A, Doulou A, Gavriil A, Dafnis I, Chroni A, Mummery C, Xilouri M, Sideras P. Activation of both transforming growth factor-beta and bone morphogenetic protein signalling pathways upon traumatic brain injury restrains pro-inflammatory and boosts tissue reparatory responses of reactive astrocytes and microglia. Brain Commun. 2019;1:fcz028.","journal-title":"Brain Commun"},{"key":"3180_CR34","doi-asserted-by":"publisher","first-page":"W537","DOI":"10.1093\/nar\/gky379","volume":"46","author":"E Afgan","year":"2018","unstructured":"Afgan E, Baker D, Batut B, van den Beek M, Bouvier D, Cech M, Chilton J, Clements D, Coraor N, Gruning BA, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 2018;46:W537\u201344.","journal-title":"Nucleic Acids Res"},{"key":"3180_CR35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"3180_CR36","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","volume":"26","author":"G Monaco","year":"2019","unstructured":"Monaco G, Lee B, Xu W, Mustafah S, Hwang YY, Carre C, Burdin N, Visan L, Ceccarelli M, Poidinger M, et al. RNA-Seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types. Cell Rep. 2019;26:1627\u201340.e7.","journal-title":"Cell Rep"},{"key":"3180_CR37","doi-asserted-by":"crossref","unstructured":"Garcia-Moreno A, Lopez-Dominguez R, Villatoro-Garcia JA, Ramirez-Mena A, Aparicio-Puerta E, Hackenberg M, Pascual-Montano A, Carmona-Saez P. Functional enrichment analysis of regulatory elements. Biomedicines. 2022;10:590.","DOI":"10.3390\/biomedicines10030590"},{"key":"3180_CR38","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3180_CR39","doi-asserted-by":"publisher","first-page":"1302489","DOI":"10.3389\/fimmu.2024.1302489","volume":"15","author":"G Divolis","year":"2024","unstructured":"Divolis G, Synolaki E, Doulou A, Gavriil A, Giannouli CC, Apostolidou A, Foster ML, Matzuk MM, Skendros P, Galani IE, Sideras P. Neutrophil-derived Activin-A moderates their pro-NETotic activity and attenuates collateral tissue damage caused by Influenza A virus infection. Front Immunol. 2024;15:1302489.","journal-title":"Front Immunol"},{"key":"3180_CR40","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/cid\/ciab437","volume":"74","author":"JA Masso-Silva","year":"2022","unstructured":"Masso-Silva JA, Moshensky A, Lam MTY, Odish MF, Patel A, Xu L, Hansen E, Trescott S, Nguyen C, Kim R, et al. Increased peripheral blood neutrophil activation phenotypes and neutrophil extracellular trap formation in critically ill coronavirus disease 2019 (COVID-19) patients: a case series and review of the literature. Clin Infect Dis. 2022;74:479\u201389.","journal-title":"Clin Infect Dis"},{"key":"3180_CR41","doi-asserted-by":"publisher","first-page":"41749","DOI":"10.1038\/srep41749","volume":"7","author":"MA Khan","year":"2017","unstructured":"Khan MA, Palaniyar N. Transcriptional firing helps to drive NETosis. Sci Rep. 2017;7:41749.","journal-title":"Sci Rep"},{"key":"3180_CR42","doi-asserted-by":"crossref","unstructured":"Radermecker C, Detrembleur N, Guiot J, Cavalier E, Henket M, d\u2019Emal C, Vanwinge C, Cataldo D, Oury C, Delvenne P, Marichal T. Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19. J Exp Med. 2020;217:e20201012.","DOI":"10.1084\/jem.20201012"},{"key":"3180_CR43","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.chest.2022.06.007","volume":"162","author":"I Melero","year":"2022","unstructured":"Melero I, Villalba-Esparza M, Recalde-Zamacona B, Jimenez-Sanchez D, Teijeira A, Argueta A, Garcia-Tobar L, Alvarez-Gigli L, Sainz C, Garcia-Ros D, et al. Neutrophil extracellular traps, local IL-8 expression, and cytotoxic T-Lymphocyte response in the lungs of patients with fatal COVID-19. Chest. 2022;162:1006\u201316.","journal-title":"Chest"},{"key":"3180_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","volume":"22","author":"IE Galani","year":"2021","unstructured":"Galani IE, Rovina N, Lampropoulou V, Triantafyllia V, Manioudaki M, Pavlos E, Koukaki E, Fragkou PC, Panou V, Rapti V, et al. Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison. Nat Immunol. 2021;22:32\u201340.","journal-title":"Nat Immunol"},{"key":"3180_CR45","doi-asserted-by":"publisher","first-page":"e1012368","DOI":"10.1371\/journal.ppat.1012368","volume":"20","author":"LE Cabrera","year":"2024","unstructured":"Cabrera LE, Jokiranta ST, Maki S, Miettinen S, Kant R, Kareinen L, Sironen T, Pietila JP, Kantele A, Kekalainen E, et al. The assembly of neutrophil inflammasomes during COVID-19 is mediated by type I interferons. PLoS Pathog. 2024;20:e1012368.","journal-title":"PLoS Pathog"},{"key":"3180_CR46","doi-asserted-by":"crossref","unstructured":"Zou Y, Sun X, Wang Y, Ye X, Tu J, Yu R, Huang P. Integrating single-cell RNA sequencing data to genome-wide association analysis data identifies significant cell types in influenza A virus infection and COVID-19. Brief Funct Genomics. 2024;23:110-7.","DOI":"10.1093\/bfgp\/elad025"},{"key":"3180_CR47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1378\/chest.07-1948","volume":"133","author":"BW Kinder","year":"2008","unstructured":"Kinder BW, Brown KK, Schwarz MI, Ix JH, Kervitsky A, King TE Jr.Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest. 2008;133:226\u201332.","journal-title":"Chest"},{"key":"3180_CR48","doi-asserted-by":"crossref","unstructured":"Mantovani S, Oliviero B, Varchetta S, Renieri A, Mondelli MU. TLRs: innate immune sentries against SARS-CoV-2 infection. Int J Mol Sci. 2023;24:8065.","DOI":"10.3390\/ijms24098065"},{"key":"3180_CR49","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41590-021-00962-w","volume":"22","author":"A Sariol","year":"2021","unstructured":"Sariol A, Perlman S. SARS-CoV-2 takes its Toll. Nat Immunol. 2021;22:801\u20132.","journal-title":"Nat Immunol"},{"key":"3180_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","volume":"147","author":"P Heukels","year":"2019","unstructured":"Heukels P, Moor CC, von der Thusen JH, Wijsenbeek MS, Kool M. Inflammation and immunity in IPF pathogenesis and treatment. Respir Med. 2019;147:79\u201391.","journal-title":"Respir Med"},{"key":"3180_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1755-1536-3-20","volume":"3","author":"GA Margaritopoulos","year":"2010","unstructured":"Margaritopoulos GA, Antoniou KM, Karagiannis K, Samara KD, Lasithiotaki I, Vassalou E, Lymbouridou R, Koutala H, Siafakas NM. Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study. Fibrogenesis Tissue Repair. 2010;3:20.","journal-title":"Fibrogenesis Tissue Repair"},{"key":"3180_CR52","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/cr.2010.150","volume":"21","author":"Q Remijsen","year":"2011","unstructured":"Remijsen Q, Vanden Berghe T, Wirawan E, Asselbergh B, Parthoens E, De Rycke R, Noppen S, Delforge M, Willems J, Vandenabeele P. Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res. 2011;21:290\u2013304.","journal-title":"Cell Res"},{"key":"3180_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fcell.2018.00109","volume":"6","author":"P Skendros","year":"2018","unstructured":"Skendros P, Mitroulis I, Ritis K. Autophagy in neutrophils: from granulopoiesis to neutrophil extracellular traps. Front Cell Dev Biol. 2018;6:109.","journal-title":"Front Cell Dev Biol"},{"key":"3180_CR54","doi-asserted-by":"publisher","first-page":"e0157454","DOI":"10.1371\/journal.pone.0157454","volume":"11","author":"G Sollberger","year":"2016","unstructured":"Sollberger G, Amulic B, Zychlinsky A. Neutrophil extracellular trap formation is independent of de novo gene expression. PLoS ONE. 2016;11:e0157454.","journal-title":"PLoS ONE"},{"key":"3180_CR55","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/bs.apcsb.2016.08.003","volume":"106","author":"DS Pisetsky","year":"2017","unstructured":"Pisetsky DS. Mechanisms of chromatin remodeling and repurposing during extracellular translocation. Adv Protein Chem Struct Biol. 2017;106:113\u201337.","journal-title":"Adv Protein Chem Struct Biol"},{"key":"3180_CR56","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/path.4359","volume":"233","author":"A Chrysanthopoulou","year":"2014","unstructured":"Chrysanthopoulou A, Mitroulis I, Apostolidou E, Arelaki S, Mikroulis D, Konstantinidis T, Sivridis E, Koffa M, Giatromanolaki A, Boumpas DT, et al. Neutrophil extracellular traps promote differentiation and function of fibroblasts. J Pathol. 2014;233:294\u2013307.","journal-title":"J Pathol"},{"key":"3180_CR57","doi-asserted-by":"crossref","unstructured":"d\u2019Alessandro M, Conticini E, Bergantini L, Cameli P, Cantarini L, Frediani B, Bargagli E. Neutrophil extracellular traps in ANCA-associated vasculitis and interstitial lung disease: a scoping review. Life (Basel). 2022;12:317.","DOI":"10.3390\/life12020317"},{"key":"3180_CR58","doi-asserted-by":"crossref","unstructured":"Matson SM, Ngo LT, Sugawara Y, Fernando V, Lugo C, Azeem I, Harrison A, Alsup A, Nissen E, Koestler D et al. Neutrophil extracellular traps linked to idiopathic pulmonary fibrosis severity and survival. medRxiv. 2024:2024.2001.2024.24301742.","DOI":"10.1101\/2024.01.24.24301742"},{"key":"3180_CR59","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s40265-023-01950-0","volume":"83","author":"F Bonella","year":"2023","unstructured":"Bonella F, Spagnolo P, Ryerson C. Current and future treatment landscape for idiopathic pulmonary fibrosis. Drugs. 2023;83:1581\u201393.","journal-title":"Drugs"},{"key":"3180_CR60","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/14728214.2024.2340723","volume":"29","author":"S MacIsaac","year":"2024","unstructured":"MacIsaac S, Somboonviboon D, Scallan C, Kolb M. Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials. Expert Opin Emerg Drugs. 2024;29:177\u201386.","journal-title":"Expert Opin Emerg Drugs"},{"key":"3180_CR61","doi-asserted-by":"crossref","unstructured":"Montero P, Milara J, Roger I, Cortijo J. Role of JAK\/STAT in interstitial lung diseases; molecular and cellular mechanisms. Int J Mol Sci. 2021;22:6211.","DOI":"10.3390\/ijms22126211"},{"key":"3180_CR62","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12931-018-0728-9","volume":"19","author":"J Milara","year":"2018","unstructured":"Milara J, Hernandez G, Ballester B, Morell A, Roger I, Montero P, Escriva J, Lloris JM, Molina-Molina M, Morcillo E, Cortijo J. The JAK2 pathway is activated in idiopathic pulmonary fibrosis. Respir Res. 2018;19:24.","journal-title":"Respir Res"},{"key":"3180_CR63","doi-asserted-by":"crossref","unstructured":"Triboulet F, Juge PA, Truchetet ME, Pham T, Roux N, Flipo RM, Leske C, Roux CH, Seror R, Basch A et al. Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study. RMD Open. 2025;11:e005062","DOI":"10.1136\/rmdopen-2024-005062"},{"key":"3180_CR64","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1056\/NEJM199409083311003","volume":"331","author":"HJ Fuchs","year":"1994","unstructured":"Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme study group. N Engl J Med. 1994;331:637\u201342.","journal-title":"N Engl J Med"},{"key":"3180_CR65","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/ppul.21388","volume":"46","author":"MW Konstan","year":"2011","unstructured":"Konstan MW, Wagener JS, Pasta DJ, Millar SJ, Jacobs JR, Yegin A, Morgan WJ. Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis. Pediatr Pulmonol. 2011;46:545\u201353.","journal-title":"Pediatr Pulmonol"},{"key":"3180_CR66","doi-asserted-by":"crossref","unstructured":"Toma A, Darwish C, Taylor M, Harlacher J, Darwish R. The use of Dornase Alfa in the management of COVID-19-associated adult respiratory distress syndrome. Crit Care Res Pract. 2021;2021:8881115.","DOI":"10.1155\/2021\/8881115"},{"key":"3180_CR67","doi-asserted-by":"publisher","first-page":"714833","DOI":"10.3389\/fimmu.2021.714833","volume":"12","author":"ZM Holliday","year":"2021","unstructured":"Holliday ZM, Earhart AP, Alnijoumi MM, Krvavac A, Allen LH, Schrum AG. Non-randomized trial of dornase alfa for acute respiratory distress syndrome secondary to Covid-19. Front Immunol. 2021;12:714833.","journal-title":"Front Immunol"},{"key":"3180_CR68","doi-asserted-by":"publisher","first-page":"109016","DOI":"10.1016\/j.clim.2022.109016","volume":"238","author":"E Gavriilidis","year":"2022","unstructured":"Gavriilidis E, Antoniadou C, Chrysanthopoulou A, Ntinopoulou M, Smyrlis A, Fotiadou I, Zioga N, Kogias D, Natsi AM, Pelekoudas C, et al. Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure. Clin Immunol. 2022;238:109016.","journal-title":"Clin Immunol"},{"key":"3180_CR69","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/atm.atm_7_23","volume":"18","author":"NN Alrajhi","year":"2023","unstructured":"Alrajhi NN. Post-COVID-19 pulmonary fibrosis: an ongoing concern. Ann Thorac Med. 2023;18:173\u201381.","journal-title":"Ann Thorac Med"},{"key":"3180_CR70","doi-asserted-by":"crossref","unstructured":"Bharat A, Querrey M, Markov NS, Kim S, Kurihara C, Garza-Castillon R, Manerikar A, Shilatifard A, Tomic R, Politanska Y et al. Lung transplantation for patients with severe COVID-19. Sci Transl Med. 2020;12:eabe4282.","DOI":"10.1126\/scitranslmed.abe4282"},{"key":"3180_CR71","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13054-022-04002-3","volume":"26","author":"C Loyer","year":"2022","unstructured":"Loyer C, Lapostolle A, Urbina T, Elabbadi A, Lavillegrand JR, Chaigneau T, Simoes C, Dessajan J, Desnos C, Morin-Brureau M, et al. Impairment of neutrophil functions and homeostasis in COVID-19 patients: association with disease severity. Crit Care. 2022;26:155.","journal-title":"Crit Care"},{"key":"3180_CR72","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-021-03570-8","volume":"595","author":"TM Delorey","year":"2021","unstructured":"Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe A, Abbondanza D, Fleming SJ, Subramanian A, Montoro DT, et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. 2021;595:107\u201313.","journal-title":"Nature"},{"key":"3180_CR73","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/s41556-021-00796-6","volume":"23","author":"S Wang","year":"2021","unstructured":"Wang S, Yao X, Ma S, Ping Y, Fan Y, Sun S, He Z, Shi Y, Sun L, Xiao S, et al. A single-cell transcriptomic landscape of the lungs of patients with COVID-19. Nat Cell Biol. 2021;23:1314\u201328.","journal-title":"Nat Cell Biol"},{"key":"3180_CR74","doi-asserted-by":"publisher","first-page":"7052","DOI":"10.1038\/s41598-021-86002-x","volume":"11","author":"AR Daamen","year":"2021","unstructured":"Daamen AR, Bachali P, Owen KA, Kingsmore KM, Hubbard EL, Labonte AC, Robl R, Shrotri S, Grammer AC, Lipsky PE. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway. Sci Rep. 2021;11:7052.","journal-title":"Sci Rep"},{"key":"3180_CR75","doi-asserted-by":"publisher","first-page":"eadl5473","DOI":"10.1126\/sciadv.adl5473","volume":"10","author":"CH Mayr","year":"2024","unstructured":"Mayr CH, Santacruz D, Jarosch S, Bleck M, Dalton J, McNabola A, Lempp C, Neubert L, Rath B, Kamp JC, et al. Spatial transcriptomic characterization of pathologic niches in IPF. Sci Adv. 2024;10:eadl5473.","journal-title":"Sci Adv"},{"key":"3180_CR76","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1038\/s41467-019-11249-y","volume":"10","author":"BM Tang","year":"2019","unstructured":"Tang BM, Shojaei M, Teoh S, Meyers A, Ho J, Ball TB, Keynan Y, Pisipati A, Kumar A, Eisen DP, et al. Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection. Nat Commun. 2019;10:3422.","journal-title":"Nat Commun"},{"key":"3180_CR77","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/imm.13419","volume":"164","author":"KT Mincham","year":"2021","unstructured":"Mincham KT, Bruno N, Singanayagam A, Snelgrove RJ. Our evolving view of neutrophils in defining the pathology of chronic lung disease. Immunology. 2021;164:701\u201321.","journal-title":"Immunology"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03180-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03180-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03180-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T14:03:06Z","timestamp":1749650586000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03180-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3180"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03180-2","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Scientific and Ethics Committees of the \u2018Attikon\u2019 General University Hospital, Athens, Greece (Approval No. 803\/23-09-2019) and the \u2018Sotiria\u2019 General Hospital of Chest Diseases, Athens, Greece (Approval No. 354\/18-7-2017 and 38\/18-01-2018). Informed consent for participation was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"213"}}